| Proximal LAD n (%) | Proximal LCX/RCA n (%) | P value (study I) * | Non-proximal LAD n (%) | P value (study II) ** |
---|---|---|---|---|---|
In-hospital outcomes | n = 408 | n = 133 | Â | n = 244 | Â |
Angiographic Success | 408 (100%) | 129 (97%) | 0.004 | 241 (98.8%) | 0.05 |
Procedural Success | 400 (98%) | 128 (96.2%) | 0.10 | 240 (98.4%) | >0.999 |
In-hospital Events | 8 (2%) | 1 (0.8%) | 0.45 | 1 (0.4%) | 0.27 |
9-month follow-up | n = 338 | n = 111 | Â | n = 211 | Â |
Major adverse cardiac events | 11 (3.3%) | 3 (2.7%) | >0.999 | 12 (5.7%) | 0.17 |
   Cardiac death | 1 (0.3%) | 1 (0.9%) | 0.43 | 2 (0.9%) | 0.56 |
   Non-fatal MI | 4(1.2%) | 1 (0.9%) | >0.999 | 2 (0.9%) | >0.999 |
   TVR | 6 (1.8%) | 2 (1.8%) | >0.999 | 7 (3.3%) | 0.17 |
TLR | 2 (0.6%) | 1 (0.9%) | 0.57 | 2 (0.9%) | 0.63 |
CABG | 4 (1.2%) | 1 (0.9%) | >0.999 | 5 (2.4%) | 0.29 |